-
Hearing loss contributes to cognitive decline after childhood cancer treatment
02/20/2026
See how radiation therapy causes sensorineural hearing loss in patients with emepdymoma which contributes to cognitive decline separate from chemotherapy.
-
James R. Downing, MD, to step down as president and CEO of St. Jude Children’s Research Hospital in late 2026
02/19/2026
Dr. Downing led St. Jude to unprecedented growth over the last 12 years.
-
Classifying pediatric brain tumors by liquid biopsy using artificial intelligence
02/17/2026
See how M-PACT, an AI-powered algorithm can sift through ctDNA in cerebrospinal fluid and molecularly classify tumors based on their DNA methylation pattern
-
Studies show that less frequent, all-injectable treatment for HIV is safe and preferred by adolescents
01/15/2026
Dive into a St. Jude co-led clinical trial finding long-acting injectable HIV treatment is safe, effective & preferred by adolescents in multiple countries.
-
Retrotransposon drives cancer by altering 3D genome structure
01/05/2026
See how LINE-1 retrotransposon jumping gene loci modulate cancer gene expression by altering three-dimensional genome architecture at select sites called HILLs.
-
CHANGE-seq-BE finds off-target changes in the genome from base editors
01/02/2026
Find how Circularization for High-throughput Analysis of Nuclease Genome-wide Effects by Sequencing Base Editors (CHANGE-seq-BE) improves finding off-targets.
-
Structural findings reveal how distinct GPCR ligands create different levels of activation
12/22/2025
Find how GPCR G-protein activation differs between ligands, with partial agonists stuck longer in “kinetic traps” of intermediate states during the process.
-
Revealing an invisible kinase state that accounts for vital biological function
12/18/2025
Learn how St. Jude scientists uncovered a hidden Src kinase state crucial for T-cell activation and cell migration, opening new paths for therapies.
-
Combination therapy shows potential to treat pediatric brain cancer ATRT
12/16/2025
See how a combo therapy of idasantulin and Selinexor stimulate the p53 pathway through MDM2 and XPO1 to treat atypical teratoid rhabdoid tumors (ATRT)
-
Accelerating drug combination discovery with machine learning
12/15/2025
Explore ComboCat, a St. Jude scientist-created system that combines machine learning and advanced liquid handling to speed up combination drug discovery.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.